No Difference in Average Interdialytic Weight Gain Observed in a Randomized Trial With a Technology-Supported Behavioral Intervention to Reduce Dietary Sodium Intake in Adults Undergoing Maintenance Hemodialysis in the United States: Primary Outcomes of the BalanceWise Study.
No Difference in Average Interdialytic Weight Gain Observed in a Randomized Trial With a Technology-Supported Behavioral Intervention to Reduce Dietary Sodium Intake in Adults Undergoing Maintenance Hemodialysis in the United States: Primary Outcomes of the BalanceWise Study.
复制标题
DOI：
10.1053/j.jrn.2015.11.006
复制
发表时间：
2016-05
期刊：
影响因子：
--
通讯作者：
Stone RA
中科院分区：
文献类型：
--
作者：
Sevick MA;Piraino BM;St-Jules DE;Hough LJ;Hanlon JT;Marcum ZA;Zickmund SL;Snetselaar LG;Steenkiste AR;Stone RA
To evaluate the efficacy of behavioral counseling combined with technology-based self-monitoring for sodium restriction in hemodialysis (HD) patients. Randomized clinical trial. Outpatient HD centers. English literate adults undergoing in-center intermittent HD for at least 3 months. Over a 16-week period, both the Intervention and the Attention Control groups were shown six educational modules on the HD diet. The Intervention group also received Social Cognitive Theory-based behavioral counseling and monitored their diets daily using hand-held computers. Average daily interdialytic weight gain (IDWGA) was calculated for every HD treatment over the observation period by subtracting the post-dialysis weight at the previous treatment time (t-1) from the pre-dialysis weight at the current treatment time (t), dividing by the number of days between treatments. Three 24-hour dietary recalls were obtained at baseline, 8 weeks, and 16 weeks, and evaluated using the Nutrient Data System for Research. 179 participants were randomized and 160 (89.4%) completed final measurements. IDWGA did not differ significantly by treatment group at any time point considered (p>0.79 for each). A significant differential change in dietary sodium intake observed at 8 weeks (−372 mg/day; p=0.05) was not sustained at 16 weeks (−191 mg/day; p=0.32). The BalanceWise Study intervention appeared to be feasible and acceptable to HD patients, although IDWGA was unchanged and the desired behavioral changes observed at 8 weeks were not sustained. Unmeasured factors may have contributed to the mixed findings, and further research is needed to identify the appropriate patients for such interventions.
登录
查看更多内容
影响因子：
0.9
作者：
Moubarac, Jean-Claude;Batal, Malek;Monteiro, Carlos
通讯作者：
Monteiro, Carlos
影响因子：
19.6
作者：
通讯作者：
--
DOI：
10.1053/j.jrn.2013.09.003
发表时间：
2014-01
期刊：
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation
影响因子：
--
作者：
Carrigan A;Klinger A;Choquette SS;Luzuriaga-McPherson A;Bell EK;Darnell B;Gutiérrez OM
通讯作者：
Gutiérrez OM
影响因子：
19.6
作者：
Flythe, Jennifer E.;Kimmel, Stephen E.;Brunelli, Steven M.
通讯作者：
Brunelli, Steven M.
影响因子：
13.2
作者：
Rahman, M;Dixit, A;Smith, MC
通讯作者：
Smith, MC